Day: April 2, 2026

Approximately 30% of FDA Warning Letters cite inadequate monitoring of Key Performance Indicators (KPIs) as a major compliance issue, highlighting their crucial role in pharmaceutical operations. KPIs provide measurable data to track process efficiency, product quality, and regulatory adherence. Proper KPI management supports risk mitigation, enhances decision-making, and ensures patient safety.